Epilepsy affects over 600,000 people in the UK, which is approximately one in every 100 people
News
JCVI advises extending COVID-19 booster programme
All adults aged 40- to 49-years-old to be offered an mRNA vaccine booster dose
Vertex receives CHMP positive opinion for Kaftrio in children with cystic fibrosis
Those eligible will have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
NICE ‘no’ for BioMarin’s Vimizin
The draft guidance has been published following an evaluation of new evidence on the use of the treatment
New drug combination highly effective in children with leukaemia
APL is an acute leukaemia, meaning it develops quickly and requires immediate treatment
New COVID-19 vaccines could target replication proteins
Researchers have said that next generation vaccines for COVID-19 should aim to induce a response against ‘replication proteins’
New positive long-term data for JAK inhibitor Olumiant in RA
Olumiant maintained a consistent safety profile in a long-term analysis of patients with rheumatoid arthritis
Updated guidelines for managing long-term effects of COVID-19 published
New guidelines from NICE, SIGN and the RCGP includes an update to original list of common symptoms
Valneva receives EU deal for COVID jab, and seeks apology from UK
Decision follows the UK government’s termination of their deal with Valneva in September
University of Oxford begins human trials of Ebola vaccine
ChAdOxl biEBOV is being tested for safety and immunogenicity, and may protect against multiple species of the virus
‘Ground-breaking’ research on inflammatory disease treatment set to be commercialised
The new research by Heriot-Watt University has identified a way of targeting an enzyme called EPAC1
SMC accepts oral therapy for relapsing multiple sclerosis
Janssen’s Ponvory accepted for use within NHS Scotland for adults RRMS patients
CN Bio inks COVID-19 research deal with iiCON
iiCON’s lead partner LSTM will independently validate CN Bio’s novel lung and lung-liver models
Sanofi invests $40m in UK gene therapy company Gyroscope Therapeutics
Funding proceeds will be used to support ongoing trials of Gyroscopes investigational gene therapy GT005
NHS staff face spring deadline for mandatory COVID vaccination
The government is expected to announce that frontline staff in England will have to be fully vaccinated against COVID-19
